ニューヨークにおける統合失調症の臨床試験
ニューヨーク内の拠点で、統合失調症に関する23件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
iTBS to Enhance Social Cognition in People With Psychosis
- Zucker Hillside Hospital, Glen Oaks
被験者募集中
18歳〜39歳 · 全性別 · 2026/10/01更新 · NCT06118268Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Radial - Manhattan, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/30更新 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Neurobehavioral Research Inc, Cedarhurst
- Evolution Research Group, Staten Island
被験者募集中第1相
18歳〜55歳 · 全性別 · 2026/09/28更新 · NCT07615426Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- NYU Child Study Center, New York
- Richmond Behavioral Associates, Staten Island
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/25更新 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
- 他2件
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, The Bronx
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0061, Great Neck
- Local Institution - 0156, Staten Island
- Local Institution - 0151, The Bronx
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/22更新 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Adams Clinical Harlem, New York
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/09/22更新 · NCT0741050752-week Open Label Safety-Tolerability Study
- Neuro-Behavioral Clinical Research, New York
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/09更新 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Local Institution - 0061, Great Neck
被験者募集中第3相
13歳〜17歳 · 全性別 · 2026/09/04更新 · NCT07288567A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, New York
- Clinical Site, Staten Island
- Clinical Site, The Bronx
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/01更新 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0037, Buffalo
- Local Institution - 0004, Monsey
- Local Institution - 0038, Rochester
- 他1件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, New York
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/08/14更新 · NCT05303064Biomarkers to Enhance Early Schizophrenia Treatment
- Feinstein Institute for Medical Research, Glen Oaks
被験者募集中第4相
18歳〜35歳 · 全性別 · 2026/07/31更新 · NCT06969755MicroRNAs as Biomarkers in First Episode Schizophrenia
- Zucker Hillside Hospital, Glen Oaks
被験者募集中健康なボランティア歓迎
15歳〜40歳 · 全性別 · 2026/07/14更新 · NCT07703670A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
- Manhattan Psychiatric Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division, White Plains
被験者募集中
18歳〜64歳 · 全性別 · 2026/06/10更新 · NCT07434479Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- NYU Langone Medical Center, New York
- New York State Psychiatric Institute, New York
- Manhattan Psychiatric Center, New York
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/05/04更新 · NCT05208190NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Staten Island
- Neurocrine Clinical Site, The Bronx
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/03/06更新 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Staten Island
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/01/12更新 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5108, New York
- Site 5077, New York
- Site 5126, White Plains
被験者募集中第2相
21歳〜55歳 · 全性別 · 2025/12/26更新 · NCT06502964Visual Perception in Schizophrenia
- University of Rochester, Rochester
被験者募集中健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2025/11/12更新 · NCT06911931Effectiveness of Motivation Skills Training (MST)
- The Bridge, Inc., New York
- New York State Office of Mental Health, New York
被験者募集中
18歳〜65歳 · 全性別 · 2025/11/05更新 · NCT05805397Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
- Zucker Hillside Hospital, New York
被験者募集中
18歳〜60歳 · 全性別 · 2025/09/25更新 · NCT05389787ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。